Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1Phase 1 1

Status

Completed 4

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 9CNS 5Genitourinary 4Gastrointestinal 4Thoracic 2Gynecologic 2Breast 2Other solid neoplasm 1NET 1Head & Neck 1Endocrine 1Dermatologic 1

Conditions

Colonic Neoplasms 3Colorectal Neoplasms 2Neoplasms 1Liver Neoplasms 1Carcinoma, Hepatocellular 1Carcinoma 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 329Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 258lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
epothilone B × Gastrointestinal × Clear all
NCT00159484 2026-05-28

Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer

University of Southern California

Phase 1/2 Completed
75 enrolled 25 charts
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00969046 2020-12-08

Dose-Escalation Study in Advanced Colon Cancer Patients

Novartis

Phase 1 Completed
60 enrolled
Gastrointestinal

Colonic Neoplasms

NCT00273312 2017-02-07

Patupilone Activity in Advanced/Metastatic Hepatocellular Carcinoma

Novartis

Phase 2 Completed
25 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00035087 2013-12-04

EPO906 Therapy in Patients With Advanced Colorectal Cancer

Novartis

Phase 2 Completed
62 enrolled
Gastrointestinal

Carcinoma, Colonic Neoplasms, Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡